Otherwise, the screening process combines maternal risk factors with mean arterial pressure (MAP), serum placental growth factor (PlGF), pregnancy-associated plasma protein A (PAPP-A), and uterine artery pulsatility index (UTPI) to identify women at high risk of developing preeclampsia (PE) [7]. The gene discussed is PGF; the disease is preeclampsia.